![]() |
|
| Discuss today stock tips at the Day Trading Stocks within the Traderji.com - Discussion forum for Stocks Commodities & Forex; Lanexss abs and KRBL could be next block busters looking to Q1 results boppanavijay... |
|
|||||||
| Notices |
![]() |
|
|
Thread Tools |
| Sponsored Links |
|
#21
|
|||
|
|||
|
Lanexss abs and KRBL could be next block busters looking to Q1 results
boppanavijay |
|
#22
|
|||
|
|||
|
go for the banking stocks as they r on a high these days
|
|
#23
|
|||
|
|||
|
Elder Pharmaceuticals
Recommendation: Buy Price target: Rs410 Current market price: Rs367 Management sounds confident Elder has been slowly and steadily expanding its presence in the domestic market through in-licencing opportunities and in the export market through contract manufacturing initiatives. The company's strategy of manufacturing its own brands as against outsourcing them has had a positive impact on its margins. Further, Elder is on its way to generate substantial cost savings by shifting its manufacturing activities to excise-free zones of Uttaranchal and Himachal Pradesh. As more products start coming from these facilities, the company will be able to reap the benefits of lower excise and tax rates. With its strong marketing agreements with foreign firms, continued launch of new products, scale up of business in the lifestyle, skin-care and pediatric areas, coupled with the effective cost-cutting measures, the company is on a growth track and will continue to show good results in the coming years. At the current market price of Rs367, the stock is trading at 13.2x its FY2007E earnings and 9.9x its FY2008E earnings, on a fully diluted basis. We maintain our Buy recommendation on Elder with a price target of Rs410. |
|
#24
|
|||
|
|||
|
Grasim Industries
Recommendation: Buy Price target: Rs3,150 Current market price: Rs2,251 Consolidating globally The Aditya Birla group has announced that it has agreed to invest US$67 million (Rs311 crore) to buy a controlling stake in the Chinese viscose staple fibre (VSF) company, Hubei Jing Wei Chemical Fibre (HJW)—a 30,000 tonne per annum (tpa) VSF manufacturer headquartered in the Hubei province of China. This move will not only give the Indian conglomerate a straight entry into the fast-growing Chinese textile market, but also will help the Birla group to consolidate its position as the largest VSF maker in the world. The Birla group, which has an annual VSF capacity of 460,000 tonne accounting for a fifth of the world's market, will fund most of the investment from its own resources. Under the agreement with China's HJW, the Birla group through its three entities, viz Grasim Industries, Thai Rayon and PT Indo Bharat Rayon will form a joint venture (JV) with HJW, wherein the Birlas will own 70% and the remaining 30% will be owned by HJW. The JV will be named Birla Jingwei Fibres Company Ltd (BJF) and will acquire the existing assets of HJW. Grasim will have a stake of a little over 30% in the JV. This is the second joint venture for the Aditya Birla group in China, the first one being Liaoning Birla Carbon Ltd. |
|
#25
|
|||
|
|||
|
Sun Pharmaceutical Industries
Recommendation: Buy Price target: Rs1,000 Current market price: Rs930 Annual report review Sun Pharma has maintained its strong performance consistently. Going forward, we expect the ramp-up in the US business and the continued momentum in the domestic formulation business to drive growth. With a strong ANDA pipeline, we are likely to see an accelerated pace of new product launches, which will drive the US business. The outlook for the company’s domestic business also remains bright as it operates in niche, high-margin lifestyle segments, which are growing at higher-than-industry rates. With the de-merger of the innovative R&D, Sun Pharma will be insulated with the inherent risks and uncertainties involving the innovative R&D process. In view of the above, we believe that the company’s valuations will improve going forward. At the current market price of Rs930, Sun Pharma is valued at 27.1x FY2007 and 23.0x FY2008 fully diluted earnings. The valuations, we believe, do not fully capture the value that Sun Pharma could command with a ramp-up in its overseas business, continued momentum in the domestic formulation space, a de-risked business model and the positive contributions of acquisitions. In view of the consistent growth and high margins, we remain positive on the company’s future prospects and maintain our Buy recommendation on the stock with a price target of Rs1,000. |
|
#26
|
|||
|
|||
|
dont forget to follow this thread, guys... u are getting sharekhan recos for free!
|
| Sponsored Links |
|
|
![]() |
| Bookmarks |
| Thread Tools | |
|
|
Similar Threads for: today stock tips
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| immediate stock tips from me!! sure shot!! | yankie | Equities | 93 | 4th July 2007 11:19 PM |
| Stock Markets to be Closed Today! | Traderji | General Chit Chat | 0 | 28th July 2005 10:24 AM |
| 10 New Stock Picks and Tips | Traderji | Stocks & Shares | 8 | 15th July 2005 10:06 PM |
| Would you pay for stock tips at Traderji.com | Neal | Equities | 39 | 1st May 2005 05:00 PM |
Indemnity, Disclaimer & Disclosure
Notice:
• By visiting Traderji.com you indicate your acceptance of our Forum
Rules Disclaimer & Disclosure and indemnify Traderji.com, its
associates and related parties of all claims howsoever resulting from
the usage of the forum.
• Disclaimer: Trading or investing in stocks & commodities
is a high risk activity. Any action you choose to take in the markets
is totally your own responsibility. Traderji.com will not be liable for
any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information.
• Disclosure: The information in this forum is neither an offer to sell nor solicitation to buy any of the securities mentioned herein.
The writers may or may not be trading in the securities mentioned.
• All names or products mentioned are trademarks or registered trademarks of their respective owners.
General Content Disclaimer Notice:
In light of our policy of encouraging candid, open exchanges of views and the rapid distribution of information originating from many sources, Traderji.com cannot determine the accuracy of information that may be uploaded to the forum. Opinions, advice and all other information expressed by participants in discussions are those of the author. You rely on such information at your own risk. You are urged to seek professional advice for specific, individual situations and not rely solely on advice or opinions given in the discussions. Since Traderji.com is an open and free discussion forum, any comments made by members of this forum in their posts reflect their own views and not of the owner or administrator of Traderji.com. Thus the owner/administrator indemnify themselves of all claims whatsoever and will not be liable or responsible for any members comments/views in this forum Traderji.com. If you find any objectionable or offensive posts made by members of this forum which you would like to bring to our notice for removal then please Contact Us.